ARMEN GARO H 4

What Happened Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 5,027 shares of common stock on February 6, 2026 as compensation (salary paid in stock). The shares were recorded at a closing price of $2.94, giving the issuance a reported value of $14,779. The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

Key Details

• Transaction type: Award/Grant (salary paid in stock) on 2026-02-06
• Shares received: 5,027 at $2.94 per share; total reported value $14,779
• Filing date / timeliness: Form 4 filed 2026-02-09; no late filing indicated
• Vesting/tax: Shares are fully vested on issuance (per plan); no separate tax-withholding code reported
• Holding: Reported shares are held in Dr. Armen's IRA accounts
• Other holdings disclosed: Dr. Armen is trustee and has investment authority for a GRAT holding 23,950 shares and is a general partner in Pixie Partners (owns 5,000 shares); he disclaims beneficial ownership to the extent of pecuniary interest in Pixie

Context This transaction reflects salary compensation converted into equity rather than a market purchase or sale. Such issuances are common for executives electing stock payment and do not, by themselves, indicate a buy or sell signal; they increase insider stock ownership in-kind but are not open-market purchases.